Comparison of CIRM and Analogous State Science Funding Programs
While CIRM fits into some of the broader patterns seen in state science and technology policy, it differs from other state-based efforts on several important dimensions. To provide an additional perspective on CIRM and better understand how it is similar to and different from other state science funding programs, the committee reviewed a small number of other state programs that are comparable in some ways to CIRM. It is important to note that the committee is not evaluating these programs, but reviewing some of their key characteristics to provide additional perspective on CIRM.
Given CIRM’s focus on stem cell research and regenerative medicine, the committee’s comparison concentrated on other state programs specific to these fields. In addition to California, five other states have adopted programs that provide funding specifically for stem cell research, including research on hES cells (Karmali et al., 2010). These state programs vary in scale, but none are as large as CIRM. New York’s program, the New York State Stem Cell Science Research Fund (NYSTEM), is closest in size, with a $600 million, 11-year commitment. Connecticut, a much smaller state than either California or New York, also has a long-term program, with a $100 million, 10-year commitment. Other states have chosen to provide funding for stem cell research without a specific long-term commitment. These states include Maryland, which has provided approximately $91 million in funding since 2006, and New Jersey and Illinois, both of which provided stem cell–specific funding in the past decade. These latter two programs were on a smaller scale than those of the other states (approximately $15 million each) and are not awarding new grants, and thus are not considered further here. CIRM’s challenge—creating and thoughtfully administering a much larger-scale funding program—distinguishes it in important ways from these smaller state stem cell programs. For this reason, the committee also included the Cancer Prevention Research Institute of Texas (CPRIT) in its comparison. While the focus of this program differs from that of CIRM, the two have numerous similarities, including the use of bond funding, a $3 billion total budget, and an approximately 10-year time frame. These programs are described briefly below and also discussed in Chapters 3 and 5.
NYSTEM: New York’s Stem Cell Program
NYSTEM dates to early 2007, when, as part of the state’s 2007-2008 budget, the Legislature and Governor Eliot Spitzer committed to providing $600 million in funding for stem cell research over 11 years. With the adoption of this law, New York became the second-largest state funder of stem cell research, behind California. Although the program is scheduled